Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-09 Sale | 2022-11-14 6:43 pm | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 162,500 | $1.5 | $243,750 | 1,975,358 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-29 Option Award | 2022-05-02 12:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 10,532 | $1 | 2,137,858 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:29 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 191,672 | $0 | 191,672 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,137,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:25 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,137,635 | $0.2 | 4,562,596 (Direct) | View |
| 2021-12-06 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 160,000 | $0 | 4,562,596 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:25 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 432,545 | $0.4 | 2,287,326 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 2,287,326 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 45,000 | $0 | 2,287,326 (Direct) | View |
| 2019-11-15 Ownership | 2022-04-26 9:18 pm | 2019-11-15 2024-11-15 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 45,000 | $0 | 60,000 (Direct) | View |